Citigroup’s Astera Labs ALAB Stock Holding History

Citigroup’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-49,000	Closed	-$6.49M	–	6034
2024 Q4	$6.49M	Sell	49,000 -107,800	-69%	-$10.1M	﹤0.01%	1712
2024 Q3	$8.21M	Buy	+156,800	New	+$7.36M	﹤0.01%	1454

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup's ALAB Position: Q2 2026 in Review

Citigroup reduced its Astera Labs (ALAB) stake by 11% in Q2 2026, selling an estimated $42.7M and leaving 1,352,136 shares worth $653M. The position accounts for 0.22% of the portfolio, ranked #85.

Citigroup first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Citigroup held 1,352,136 shares of Astera Labs worth $653M as of Q2 2026.
Citigroup sold 160,918 Astera Labs shares in Q2 2026, an estimated $42.7M.
Astera Labs made up 0.22% of Citigroup's portfolio in Q2 2026, its #85 holding.
Citigroup first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.